LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 658 | 757 | 3938 | 0.1922 | 0.0557 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 658 | 673 | 3908 | 0.1722 | 0.0087 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 658 | 695 | 3953 | 0.1758 | 0.0213 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 658 | 780 | 3938 | 0.1981 | 0.0680 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 658 | 737 | 3908 | 0.1886 | 0.0450 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 658 | 773 | 3953 | 0.1955 | 0.0641 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 658 | 864 | 3938 | 0.2194 | 0.1112 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 658 | 765 | 3908 | 0.1957 | 0.0603 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 658 | 795 | 3953 | 0.2011 | 0.0757 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 658 | 798 | 3938 | 0.2026 | 0.0775 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 658 | 3833 | 3705 | 1.0343 | 1.0272 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 658 | 3923 | 3807 | 1.0303 | 1.0237 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 658 | 3670 | 3769 | 0.9736 | 0.9788 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 658 | 3681 | 3705 | 0.9933 | 0.9946 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 658 | 3750 | 3807 | 0.9849 | 0.9880 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 658 | 3699 | 3769 | 0.9812 | 0.9850 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 658 | 3600 | 3705 | 0.9714 | 0.9769 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 658 | 3555 | 3807 | 0.9337 | 0.9465 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 658 | 3748 | 3769 | 0.9942 | 0.9954 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 658 | 3638 | 3705 | 0.9817 | 0.9852 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 658 | 3681 | 3807 | 0.9668 | 0.9735 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 658 | 3697 | 3769 | 0.9807 | 0.9846 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 658 | 3571 | 3705 | 0.9636 | 0.9705 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 658 | 3803 | 3807 | 0.9988 | 0.9991 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 658 | 3815 | 3769 | 1.0120 | 1.0095 |